NO20080947L - Terapeutisk middel for hypertensjon - Google Patents

Terapeutisk middel for hypertensjon

Info

Publication number
NO20080947L
NO20080947L NO20080947A NO20080947A NO20080947L NO 20080947 L NO20080947 L NO 20080947L NO 20080947 A NO20080947 A NO 20080947A NO 20080947 A NO20080947 A NO 20080947A NO 20080947 L NO20080947 L NO 20080947L
Authority
NO
Norway
Prior art keywords
therapeutic agent
hypertension
compound
formula
pharmaceutically acceptable
Prior art date
Application number
NO20080947A
Other languages
English (en)
Norwegian (no)
Inventor
Hideo Tsuruta
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of NO20080947L publication Critical patent/NO20080947L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO20080947A 2005-08-29 2008-02-26 Terapeutisk middel for hypertensjon NO20080947L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005248212 2005-08-29
PCT/JP2006/316878 WO2007026651A1 (ja) 2005-08-29 2006-08-28 高血圧症治療剤

Publications (1)

Publication Number Publication Date
NO20080947L true NO20080947L (no) 2008-05-16

Family

ID=37808741

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080947A NO20080947L (no) 2005-08-29 2008-02-26 Terapeutisk middel for hypertensjon

Country Status (12)

Country Link
US (1) US9650408B2 (de)
EP (1) EP1921085B1 (de)
JP (1) JP5094400B2 (de)
KR (1) KR20080037678A (de)
CN (1) CN101243103B (de)
AU (1) AU2006285902B9 (de)
BR (1) BRPI0615346A2 (de)
CA (1) CA2620553C (de)
NO (1) NO20080947L (de)
RU (1) RU2415147C2 (de)
TW (1) TW200740442A (de)
WO (1) WO2007026651A1 (de)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447941A (en) * 1993-12-21 1995-09-05 Eli Lilly And Company Methods of inhibiting pulmonary hypertensive diseases with raloxifene and related benzothiophenes
US6548491B2 (en) 1997-12-24 2003-04-15 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6503896B1 (en) * 1997-12-24 2003-01-07 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
GB9827121D0 (en) 1998-12-09 1999-02-03 Orion Corp Agent for lowering endothelin levels
AU7896100A (en) 1999-10-14 2001-04-23 Endorecherche Inc. Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance
GB2374412A (en) 2001-04-11 2002-10-16 Karobio Ab Hypertension treatment and assay

Also Published As

Publication number Publication date
CA2620553A1 (en) 2007-03-08
BRPI0615346A2 (pt) 2011-05-17
CN101243103A (zh) 2008-08-13
TW200740442A (en) 2007-11-01
AU2006285902A1 (en) 2007-03-08
RU2415147C2 (ru) 2011-03-27
RU2008112142A (ru) 2009-10-10
US20090281071A1 (en) 2009-11-12
CA2620553C (en) 2013-05-07
US9650408B2 (en) 2017-05-16
WO2007026651A1 (ja) 2007-03-08
EP1921085A1 (de) 2008-05-14
AU2006285902B9 (en) 2012-07-05
JPWO2007026651A1 (ja) 2009-03-05
EP1921085B1 (de) 2012-08-08
KR20080037678A (ko) 2008-04-30
CN101243103B (zh) 2012-04-18
EP1921085A4 (de) 2010-08-25
AU2006285902B2 (en) 2012-06-14
JP5094400B2 (ja) 2012-12-12

Similar Documents

Publication Publication Date Title
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
DK1585739T3 (da) Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer
MX2010004232A (es) Compuesto de indolina de pirimidilo.
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
NO20082389L (no) 2,3,4-trifenylimidazolinderivater som inhibitor av interaksjonen mellom P53- og MDM2-proteiner for anvendelse som antikreftmidler
NO20081970L (no) Sulfonamidderivat med PGD2-reseptorantagonistaktivitet
EE200200485A (et) Farmatseutilised kompositsioonid, mis sisaldavad asetidiini derivaate, uued asetidiini derivaadid ja nende valmistamismeetodid
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20082643L (no) Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
HRP20090281T1 (hr) 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti
NO20092033L (no) Nye forbindelser
NO20081844L (no) Terapeutiske forbindelser
NO20032208D0 (no) Benzodiazepinderivater som GABA A reseptormodulatorer
SE0302760D0 (sv) New compounds
CO5580767A2 (es) Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso
DK1694318T3 (da) (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
NO20060195L (no) Kinolylamidderivater som CCR-5-antagonister
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20032261L (no) Medisinske preparater
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application